SPONSORED CONTENT
×

Sponsored Content is a "Paid For" Press Release distribution arrangement. Purely a Commercial Arrangement, brands and advertisers pay to be featured and to get this content published.

The Editorial/Content team at Business Standard has not contributed to writing/editing this article.

To get your brand featured in this Section write to assist@bsmail.in

ZS PRIZE bestows an honorary mention to MedPrime's MICALYS, an all-in-one microscope machine that can reach India's hinterlands

July 14, 2021 14:00 IST | ANI Press Release
Tennis player James Blake
ZS

You would like to read

Mumbai (Maharashtra) [India], July 14 (ANI/PRNewswire): MedPrime's MICALYS-a single machine that can address all the microscopy needs of a diagnostic lab, on 2 July, 2021, received an honorary mention at ZS's inaugural healthcare innovation program - ZS PRIZE.

MICALYS is an all-in-one microscopy machine that can effectively replace the traditionally prevalent methods of microscopy. It is a digital microscopy system with modular software packages that can perform multiple functions such as whole slide scanning, telepathology, AI-powered sample analysis and manual microscopy.

A pay-per-use model and flexibility in operation allow it to suit the needs and budgets of all customer groups.

There are only around 5500 practicing pathologists in India in contrast to the present number of diagnostic labs which is about 2.5 lakhs. There is a significant shortage of pathologists, especially in rural areas and smaller towns, due to the decline in the number of pathologists and the increasing number of chronic disease patients.

In order to effectively handle multiple labs, most pathologists delegate tasks to lab technicians. Pathologists usually travel between multiple labs in a day to collect samples for analysis, especially from rural areas as they do not have proper infrastructure for the same. COVID-19 has further compounded the problem because of restrictions around the movement of people and goods, which increases the time it takes to file patient reports.

Speaking about the solution, Greeshma Unnikrishnan, Co-founder of MICALYS, says that "Pathologists usually travel to multiple labs during the day, and samples from rural areas are most often transported to larger cities for analysis. Since Covid-19 has restricted movement, the problem has been further intensified, resulting in delayed report generation. MICALYS is a single machine that can address all the microscopy needs of a diagnostic lab, and effectively replace the traditional methods of microscopy being used today."

In the award ceremony of ZS PRIZE, Ravi Venkatesan, Jury Chairman of ZS PRIZE and former Chairman, Microsoft, concludes with, "We witnessed India's worst public health crisis, and while everybody was affected, once again, it is the poor, weak and old who were disproportionately impacted. The second wave of COVID-19 highlighted the urgent need for a tremendous amount of innovation to make healthcare in India preventive, affordable, and accessible. This can only happen if many more people across our country are inspired to apply their minds and technology to solving healthcare issues with ideas both small and large."

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

 

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

ZS PRIZE bestows an honorary mention to MedPrime's MICALYS, an all-in-one microscope machine that can reach India's hinterlands

Mumbai (Maharashtra) [India], July 14 (ANI/PRNewswire): MedPrime's MICALYS-a single machine that can address all the microscopy needs of a diagnostic lab, on 2 July, 2021, received an honorary mention at ZS's inaugural healthcare innovation program - ZS PRIZE.

MICALYS is an all-in-one microscopy machine that can effectively replace the traditionally prevalent methods of microscopy. It is a digital microscopy system with modular software packages that can perform multiple functions such as whole slide scanning, telepathology, AI-powered sample analysis and manual microscopy.

A pay-per-use model and flexibility in operation allow it to suit the needs and budgets of all customer groups.

There are only around 5500 practicing pathologists in India in contrast to the present number of diagnostic labs which is about 2.5 lakhs. There is a significant shortage of pathologists, especially in rural areas and smaller towns, due to the decline in the number of pathologists and the increasing number of chronic disease patients.

In order to effectively handle multiple labs, most pathologists delegate tasks to lab technicians. Pathologists usually travel between multiple labs in a day to collect samples for analysis, especially from rural areas as they do not have proper infrastructure for the same. COVID-19 has further compounded the problem because of restrictions around the movement of people and goods, which increases the time it takes to file patient reports.

Speaking about the solution, Greeshma Unnikrishnan, Co-founder of MICALYS, says that "Pathologists usually travel to multiple labs during the day, and samples from rural areas are most often transported to larger cities for analysis. Since Covid-19 has restricted movement, the problem has been further intensified, resulting in delayed report generation. MICALYS is a single machine that can address all the microscopy needs of a diagnostic lab, and effectively replace the traditional methods of microscopy being used today."

In the award ceremony of ZS PRIZE, Ravi Venkatesan, Jury Chairman of ZS PRIZE and former Chairman, Microsoft, concludes with, "We witnessed India's worst public health crisis, and while everybody was affected, once again, it is the poor, weak and old who were disproportionately impacted. The second wave of COVID-19 highlighted the urgent need for a tremendous amount of innovation to make healthcare in India preventive, affordable, and accessible. This can only happen if many more people across our country are inspired to apply their minds and technology to solving healthcare issues with ideas both small and large."

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22